Kolon Life Science's latest marketcap:
As of 08/15/2025, Kolon Life Science's market capitalization has reached $271.91 M. According to our data, Kolon Life Science is the 18550th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 271.91 M |
| Revenue (ttm) | 120.71 M |
| Net Income (ttm) | -56,202,304.15 |
| Shares Out | 12.42 M |
| EPS (ttm) | -4.69 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/28/2016 |
| Earnings Date | 08/13/2025 |
Kolon Life Science's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/15/2025 | ₩377.67 B | $271.91 M | 31.09% | 18550 |
| 12/30/2024 | ₩285.74 B | $191.44 M | -2.58% | 19250 |
| 12/28/2023 | ₩293.3 B | $225.84 M | -6.2% | 18089 |
| 12/29/2022 | ₩312.7 B | $247.03 M | -36.58% | 16776 |
| 12/30/2021 | ₩493.06 B | $414.17 M | 48.78% | 14544 |
| 12/30/2020 | ₩331.41 B | $304.9 M | 60.94% | 14450 |
| 12/30/2019 | ₩205.92 B | $177.09 M | -75.77% | 15348 |
| 12/28/2018 | ₩849.91 B | $756.42 M | -29.41% | 7165 |
| 12/28/2017 | ₩1.2 T | $1.12 B | 34.8% | 6649 |
| 12/29/2016 | ₩893.19 B | $732.42 M | -32.72% | 7884 |
Company Profile
About Kolon Life Science Inc.
Kolon Life Science Inc. is a biotechnology company specializing in the development of innovative cell and gene therapy products. Headquartered in Seoul, South Korea, the company was founded in 2000 and has since been at the forefront of biopharmaceutical advancements.
Key Product Candidates
- KLS-2031: Currently in Phase 1 clinical trials for the treatment of neuropathic pain.
- KLS-3021: An oncolytic viral therapy in pre-clinical development.
Additional Services & Offerings
- Supply of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates.
- Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services.
- Pyrithione antimicrobial solutions for personal care and industrial applications.
Corporate Background
Formerly known as Korea Tissuegene Asia, Ltd., the company rebranded to Kolon Life Science Inc. in January 2006.
Frequently Asked Questions
-
What is Kolon Life Science's (KOSDAQ-102940) current market cap?As of 08/15/2025, Kolon Life Science (including the parent company, if applicable) has an estimated market capitalization of $271.91 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Kolon Life Science (KOSDAQ-102940) rank globally by market cap?Kolon Life Science global market capitalization ranking is approximately 18550 as of 08/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.